Table 3 Profiles of patients who underwent liver resection after neoadjuvant HAIC
Case | Gender/age | Etiology | HAIC cycle | AFP (initial-preoperative) | Bilobar HCC | PVTT | Extrahepatic metastasis | Resection | Margin | Recurrence (time/site) (months) | Survival time (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | F/73 | HBV | 6 | 3170–99.4 | No | Yes | Yes (LNs) | Minor | Tumor-free | No | 81 |
2 | M/44 | HBV | 6 | 5845–2.8 | No | Yes | No | Major | Tumor-free | No | 120 |
3 | M/61 | HBV | 8 | 11.74–8.8 | No | Yes | No | Major | Tumor-free | 18/lung | 46 |
4 | M/40 | HBV | 4 | 158.0–432.2 | No | Yes | No | Major | Tumor-free | 2/liver | 18 |
5 | M/42 | HBV | 6 | 950–60.2 | No | Yes | No | Major | Tumor-free | 13/lung | 31 |
6 | M/53 | HBV | 4 | 369.9–337.7 | No | Yes | No | Major | Tumor-free | 2/liver | 10 |
7 | F/48 | HBV | 6 | 188663–40762 | Yes | No | No | Minor | Tumor-free | 3/liver | 37 |
8 | M/44 | HBV | 7 | 7.5–6.7 | Yes | Yes | No | Minor | Tumor-free | 10/liver | 33 |
9 | M/56 | HBV | 3 | 911.6–23.1 | No | Yes | No | Major | Tumor-free | 47/liver | 68 |
10 | M/47 | HBV | 6 | 1038–701.1 | Yes | No | No | Major | Tumor-free | 13/liver, lung | 43 |
11 | F/39 | HBV | 8 | 121000–6047 | Yes | Yes | No | Major | Tumor-involved | 7/liver | 20 |
12 | M/46 | HBV | 6 | 188.6–17.2 | Yes | Yes | No | Minor | Tumor-free | 3/liver | 67 |